Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Schmid

Showing results (501-510 of 549) with videos related to

Pageof 55
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2016
Phase II Randomized Preoperative Window-of-Opportunity Study of the PI3K Inhibitor Pictilisib Plus Anastrozole Compared With Anastrozole Alone in Patients With Estrogen Receptor-Positive Breast CancerPeter Schmid, Sarah E Pinder, Duncan Wheatley, et al.
Allergy|June 23, 2019
Biomarkers and clinical characteristics of autoimmune chronic spontaneous urticaria: Results of the PURIST StudyNicole Schoepke, Riccardo Asero, André Ellrich, et al.
Nature|November 19, 2011
Observed increase in local cooling effect of deforestation at higher latitudesXuhui Lee, Michael L Goulden, David Y Hollinger, et al.
Nature Medicine|January 21, 2025
Pembrolizumab and chemotherapy in high-risk, early-stage, ER<sup>+</sup>/HER2<sup>-</sup> breast cancer: a randomized phase 3 trialFatima Cardoso, Joyce O'Shaughnessy, Zhenzhen Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2024
A Preoperative Window-of-Opportunity Study of Oral SERD, Imlunestrant, in Newly Diagnosed ER-Positive, HER2-Negative Early Breast Cancer: Results from the EMBER-2 StudyPatrick Neven, Nicole Stahl, Maria Vidal, et al.
British Journal of Cancer|April 24, 2024
Real world study of sacituzumab govitecan in metastatic triple-negative breast cancer in the United KingdomDaire Hanna, Sophie Merrick, Aruni Ghose, et al.
Allergo Journal International|June 30, 2015
Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Association of German Allergologists (AeDA), the Austrian Society for Allergy and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Dermatology (DDG), the German Society of Oto- Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Pneumology (GPP), the German Respiratory Society (DGP), the German Association of ENT Surgeons (BV-HNO), the Professional Federation of Paediatricians and Youth Doctors (BVKJ), the Federal Association of Pulmonologists (BDP) and the German Dermatologists Association (BVDD)Oliver Pfaar, Claus Bachert, Albrecht Bufe, et al.
Allergy|April 20, 2020
In-vivo diagnostic test allergens in Europe: A call to action and proposal for recovery plan-An EAACI position paperLudger Klimek, Hans J Hoffmann, Ayse F Kalpaklioglu, et al.
Nature Cancer|January 6, 2026
Evaluating progesterone receptor agonist megestrol plus letrozole for women with early-stage estrogen-receptor-positive breast cancer: the window-of-opportunity, randomized, phase 2b, PIONEER trialRebecca A Burrell, Sanjeev Kumar, Elena Provenzano, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 4, 2024
Optimal [<sup>18</sup>F]FDG PET/CT Cutoff for Pathologic Complete Response in HER2-Positive Early Breast Cancer Patients Treated with Neoadjuvant Trastuzumab and Pertuzumab in the PHERGain TrialGeraldine Gebhart, Marleen Keyaerts, Thomas Guiot, et al.
Pageof 55

Showing results (501-510 of 549) with videos related to

Sort By:
Pageof 55
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2016
Phase II Randomized Preoperative Window-of-Opportunity Study of the PI3K Inhibitor Pictilisib Plus Anastrozole Compared With Anastrozole Alone in Patients With Estrogen Receptor-Positive Breast CancerPeter Schmid, Sarah E Pinder, Duncan Wheatley, et al.
Allergy|June 23, 2019
Biomarkers and clinical characteristics of autoimmune chronic spontaneous urticaria: Results of the PURIST StudyNicole Schoepke, Riccardo Asero, André Ellrich, et al.
Nature|November 19, 2011
Observed increase in local cooling effect of deforestation at higher latitudesXuhui Lee, Michael L Goulden, David Y Hollinger, et al.
Nature Medicine|January 21, 2025
Pembrolizumab and chemotherapy in high-risk, early-stage, ER<sup>+</sup>/HER2<sup>-</sup> breast cancer: a randomized phase 3 trialFatima Cardoso, Joyce O'Shaughnessy, Zhenzhen Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2024
A Preoperative Window-of-Opportunity Study of Oral SERD, Imlunestrant, in Newly Diagnosed ER-Positive, HER2-Negative Early Breast Cancer: Results from the EMBER-2 StudyPatrick Neven, Nicole Stahl, Maria Vidal, et al.
British Journal of Cancer|April 24, 2024
Real world study of sacituzumab govitecan in metastatic triple-negative breast cancer in the United KingdomDaire Hanna, Sophie Merrick, Aruni Ghose, et al.
Allergo Journal International|June 30, 2015
Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Association of German Allergologists (AeDA), the Austrian Society for Allergy and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Dermatology (DDG), the German Society of Oto- Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Pneumology (GPP), the German Respiratory Society (DGP), the German Association of ENT Surgeons (BV-HNO), the Professional Federation of Paediatricians and Youth Doctors (BVKJ), the Federal Association of Pulmonologists (BDP) and the German Dermatologists Association (BVDD)Oliver Pfaar, Claus Bachert, Albrecht Bufe, et al.
Allergy|April 20, 2020
In-vivo diagnostic test allergens in Europe: A call to action and proposal for recovery plan-An EAACI position paperLudger Klimek, Hans J Hoffmann, Ayse F Kalpaklioglu, et al.
Nature Cancer|January 6, 2026
Evaluating progesterone receptor agonist megestrol plus letrozole for women with early-stage estrogen-receptor-positive breast cancer: the window-of-opportunity, randomized, phase 2b, PIONEER trialRebecca A Burrell, Sanjeev Kumar, Elena Provenzano, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 4, 2024
Optimal [<sup>18</sup>F]FDG PET/CT Cutoff for Pathologic Complete Response in HER2-Positive Early Breast Cancer Patients Treated with Neoadjuvant Trastuzumab and Pertuzumab in the PHERGain TrialGeraldine Gebhart, Marleen Keyaerts, Thomas Guiot, et al.
Pageof 55